United States Copper Index Fund vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? United States Copper Index Fund trades at $40.22 (market cap $708.28M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.49 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 35.7× United States Copper Index Fund's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while United States Copper Index Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold United States Copper Index Fund for 48 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| CPER | RPRX | |
|---|---|---|
Market Cap | $708.28M | $25.27B |
Volume | 339,046 | 3,671,183 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $41.43 | $63.96 |
52-Week Low | $30.27 | $35.44 |
Typical Hold Time | 48 Days | 0 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Signals from Pluang's Aura AI — not financial advice
CPER is trading at $39.81, down 0.55% on the day, with a neutral technical signal overall. The stock shows bullish momentum in moving averages but neutral oscillators, with key support at $39 and resistance at $40. Recent news highlights strong copper demand driven by AI infrastructure needs, though copper prices have shown volatility with recent declines.
The outlook for CPER is mixed, with positive copper demand fundamentals balanced by near-term price volatility. Investment opportunities center on exposure to copper's role in AI and electrification trends, while risks include commodity price swings and potential supply chain disruptions. Wall Street sentiment appears cautiously optimistic given copper's strategic importance.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
CPER is a commodity ETF that tracks the price of copper futures via the SummerHaven Copper Index. It provides direct exposure to the 'red metal' using a rules-based strategy to select futures contracts, making it a key tool for hedging or betting on industrial growth and electrification.
Read more on CPER →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →